MarginsXMarginsX
Home › Markets › RVPH

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

RVPH is quoted over the counter, not listed on an exchange. Reviva Pharmaceuticals Holdings, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.3000
-15.1% on the day
1-year return
-97.0%
Market cap
$3.9M
Nano cap. From the Nov 16, 2026 close × 13.1M shares (10-Q cover page, Nov 10, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerRVPH, quoted over the counter
SEC CIK0001742927
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressCupertino, CA
Incorporated inDE

Warning signs

Cash runway
15.1 months
$17.5M cash at September 30, 2026
Share count, 1 year
+127.9%
2025-11-11 to 2026-11-10 · +1057.6% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of one year after the date the consolidated financial statements are issued."
10-Q 2026-11-13
Cash and burn$17.5M cash; operating cash flow -$3.5M a quarter.Report 2026-09-30
Shares outstanding13,110,377 (2026-11-10); 115,058,619 a year earlier; 22,650,266 three years earlier. 1y figure adjusted for split (1-for-20 overall); 3y figure adjusted for split (1-for-20 overall).Cover page 2026-11-10
Reverse splits, 3 years1; latest 1-for-20 on 2026-03-09Source 2026-03-09
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-03-19
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-05-13
Delisting25-NSE filed25-NSE 2026-07-10
AuditorBaker Tilly US, LLP, San Francisco, California, United States; changed auditors 1 time in 24 months8-K 4.01 2025-06-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$2.3M-$2.2M$17.5M$44KNeeds four quarters10-Q 2026-11-13
Q2 2026
2026-06-30
Not filed-$2.4M-$2.1M$19.9M$144KNeeds four quarters10-Q 2026-08-12
Q1 2026
2026-03-31
Not filed-$3.2M-$3.8M$22.2M$231KNeeds four quarters10-Q 2026-05-13
Q4 2025
2025-12-31
Not filed-$3.4M-$5.8M$14.4M$407KNeeds four quarters10-K 2026-03-30
Q3 2025
2025-09-30
Not filed-$4.0M-$5.6M$13.2M$0Needs four quarters10-Q 2026-11-13
Q2 2025
2025-06-30
Not filed-$6.1M-$5.0M$10.4M$113KNeeds four quarters10-Q 2026-08-12
Q1 2025
2025-03-31
Not filed-$6.4M-$8.2M$5.3M$224KNeeds four quarters10-Q 2026-05-13
Q4 2024
2024-12-31
Not filed-$6.3M-$9.1M$13.5M$458KNeeds four quarters10-K 2026-03-30

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-03-19
Latest annual report10-K2026-03-30
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-13
Latest proxyDEF 14A2026-11-09

Source: SEC EDGAR submissions feed, 417 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier